Treatments Recruiting Phase 2 / 3 Trials for Methylprednisolone (DB00959)

Also known as: Treatment / Therapy / Therapeutics / Therapeutic procedure NOS / Therapeutic procedure

IndicationStatusPhase
DBCOND0024573 (Treatments)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04942002Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis TrialTreatment